Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

research Correction to: An Evaluation of the Federal Adverse Events Reporting System Data on Adverse Effects of 5-Alpha Reductase Inhibitors

September 2021 in “World journal of urology”

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports

research Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports

June 2025 in “Pharmaceuticals”

Finasteride use may increase suicidality risk, especially in young men.

research A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome

35 citations , June 2018 in “Urology”

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

research The Potential Involvement of Cholinergic System in Finasteride Induced Cognitive Dysfunction

November 2020 in “Psychoneuroendocrinology”

Finasteride might affect memory by impacting cholinergic system.

research Sun Behaviors and Quality of Life After First Cutaneous Melanoma Diagnosis

August 2018 in “Journal of The American Academy of Dermatology”

Finasteride use for hair loss is linked to an increased risk of suicidal thoughts and a higher risk of suicide.

View more "federal adverse event reporting system" in research →

Community Join

5 / 26 results

community Why is Finasteride seen as “scary” for men, but hormonal birth control is totally normalized for women?

in Finasteride/Dutasteride 757 upvotes 11 months ago

Finasteride is seen as risky for men due to side effects like erectile dysfunction, while hormonal birth control for women is normalized despite its side effects. The discussion points out a double standard influenced by societal and gender norms.

community Can we all agree that PP405 is now 4 years away

in Chat 94 upvotes 6 months ago

PP405 is expected to be available in 2028, with ongoing discussions about its timeline and potential effectiveness. Current treatments mentioned include sublingual Minoxidil and Vederamicd, with some users experiencing side effects from oral Minoxidil.

community Should I give minoxidil a try or should I wait to see if I can get any more results from my regimen (fin, Ru58841, microneedling) almost at the 1year mark since starting also wondering if I can mix my ru58841 powder into minoxidil and just use that as my solvent

in Minoxidil 53 upvotes 3 years ago

The conversation discusses whether to add minoxidil to an existing hair loss treatment regimen that includes finasteride, RU58841, and microneedling. Some users suggest trying minoxidil and monitoring for side effects, while others advise waiting to see if current treatments improve results after one year.

community Improve my stack (without Minoxidil)

in Product 37 upvotes 2 years ago

The conversation discusses improving a hair loss treatment stack without using Minoxidil. Microneedling is suggested, Alpecin is deemed ineffective, and there are concerns about the safety of Minoxidil compared to finasteride.

community Federal Grant Cuts have impacted PP405 related research

in Technology 461 upvotes 6 months ago

Federal funding cuts have delayed PP405 research, affecting hair loss treatment progress, though clinical trials will continue. The discussion highlights PP405's potential compared to minoxidil and finasteride and stresses the importance of government-funded research.

View more "federal adverse event reporting system" in community →